Teladoc Health, Inc. (NYSE: TDOC) Stock Competitors & Peer Comparison
See TDOC's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TDOC and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TDOC | $6.50 | +2.20% | 1.2B | -6.57 | -$0.99 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $59.13 | -2.91% | 11.6B | 47.69 | $1.24 | N/A |
| BTSGU | $195.51 | -3.30% | 11.5B | 176.79 | $1.11 | N/A |
| TEM | $64.04 | -9.41% | 11.2B | -128.08 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $96.37 | +3.19% | 8.1B | 22.52 | $4.28 | N/A |
| TXG | $61.54 | -5.10% | 7.8B | -104.31 | -$0.59 | N/A |
| HNGE | $87.35 | -5.92% | 6.8B | 46.70 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
TDOC vs GEHCV Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas GEHCV's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, TDOC is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
TDOC vs BTSG Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, BTSG has a market cap of 11.6B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while BTSG trades at $59.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas BTSG's P/E ratio is 47.69. In terms of profitability, TDOC's ROE is -0.13%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, TDOC is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
TDOC vs BTSGU Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, BTSGU has a market cap of 11.5B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while BTSGU trades at $195.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas BTSGU's P/E ratio is 176.79. In terms of profitability, TDOC's ROE is -0.13%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, TDOC is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
TDOC vs TEM Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, TEM has a market cap of 11.2B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while TEM trades at $64.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas TEM's P/E ratio is -128.08. In terms of profitability, TDOC's ROE is -0.13%, compared to TEM's ROE of -0.55%. Regarding short-term risk, TDOC is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
TDOC vs SGFY Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SGFY's P/E ratio is 70.91. In terms of profitability, TDOC's ROE is -0.13%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, TDOC is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
TDOC vs HQY Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, HQY has a market cap of 8.1B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while HQY trades at $96.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas HQY's P/E ratio is 22.52. In terms of profitability, TDOC's ROE is -0.13%, compared to HQY's ROE of +0.11%. Regarding short-term risk, TDOC is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
TDOC vs TXG Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, TXG has a market cap of 7.8B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while TXG trades at $61.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas TXG's P/E ratio is -104.31. In terms of profitability, TDOC's ROE is -0.13%, compared to TXG's ROE of -0.09%. Regarding short-term risk, TDOC is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
TDOC vs HNGE Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while HNGE trades at $87.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas HNGE's P/E ratio is 46.70. In terms of profitability, TDOC's ROE is -0.13%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, TDOC is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
TDOC vs RCM Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas RCM's P/E ratio is -102.21. In terms of profitability, TDOC's ROE is -0.13%, compared to RCM's ROE of +0.00%. Regarding short-term risk, TDOC is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check RCM's competition here
Waystar Holding Corp. (NASDAQ: WAY)
TDOC vs WAY Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, WAY has a market cap of 5B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while WAY trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas WAY's P/E ratio is 17.38. In terms of profitability, TDOC's ROE is -0.13%, compared to WAY's ROE of +0.04%. Regarding short-term risk, TDOC is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check WAY's competition here
Doximity, Inc. (NYSE: DOCS)
TDOC vs DOCS Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while DOCS trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas DOCS's P/E ratio is 17.47. In terms of profitability, TDOC's ROE is -0.13%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, TDOC is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check DOCS's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
TDOC vs HTFL Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, HTFL has a market cap of 4.1B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while HTFL trades at $47.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas HTFL's P/E ratio is -23.77. In terms of profitability, TDOC's ROE is -0.13%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, TDOC is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
TDOC vs ONEM Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas ONEM's P/E ratio is -7.77. In terms of profitability, TDOC's ROE is -0.13%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, TDOC is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
TDOC vs PRVA Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, PRVA has a market cap of 2.6B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while PRVA trades at $20.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas PRVA's P/E ratio is 99.00. In terms of profitability, TDOC's ROE is -0.13%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, TDOC is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
TDOC vs NXGN Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas NXGN's P/E ratio is -266.00. In terms of profitability, TDOC's ROE is -0.13%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, TDOC is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
TDOC vs OMCL Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while OMCL trades at $33.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas OMCL's P/E ratio is 17.32. In terms of profitability, TDOC's ROE is -0.13%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, TDOC is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check OMCL's competition here
Omada Health (NASDAQ: OMDA)
TDOC vs OMDA Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while OMDA trades at $23.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas OMDA's P/E ratio is 338.43. In terms of profitability, TDOC's ROE is -0.13%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, TDOC is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
TDOC vs AGTI Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas AGTI's P/E ratio is -71.79. In terms of profitability, TDOC's ROE is -0.13%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, TDOC is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
TDOC vs CERT Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CERT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CERT's P/E ratio is 20.87. In terms of profitability, TDOC's ROE is -0.13%, compared to CERT's ROE of -0.07%. Regarding short-term risk, TDOC is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
TDOC vs GDRX Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while GDRX trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas GDRX's P/E ratio is 11.03. In terms of profitability, TDOC's ROE is -0.13%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, TDOC is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check GDRX's competition here
HealthStream, Inc. (NASDAQ: HSTM)
TDOC vs HSTM Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, HSTM has a market cap of 858.3M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while HSTM trades at $29.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas HSTM's P/E ratio is 40.81. In terms of profitability, TDOC's ROE is -0.13%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, TDOC is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
TDOC vs CCLDO Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CCLDO's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CCLDO's competition here
Phreesia, Inc. (NYSE: PHR)
TDOC vs PHR Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, PHR has a market cap of 750.4M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while PHR trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas PHR's P/E ratio is 43.36. In terms of profitability, TDOC's ROE is -0.13%, compared to PHR's ROE of +0.03%. Regarding short-term risk, TDOC is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
TDOC vs SOPH Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SOPH has a market cap of 682.9M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SOPH trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SOPH's P/E ratio is -7.33. In terms of profitability, TDOC's ROE is -0.13%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, TDOC is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SOPH's competition here
Claritev Corporation (NYSE: CTEV)
TDOC vs CTEV Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CTEV has a market cap of 669.3M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CTEV trades at $39.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CTEV's P/E ratio is -2.31. In terms of profitability, TDOC's ROE is -0.13%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, TDOC is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
TDOC vs MPLN-WT Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, TDOC is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
TDOC vs ACCD Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas ACCD's P/E ratio is -3.08. In terms of profitability, TDOC's ROE is -0.13%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, TDOC is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
TDOC vs SHCR Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SHCR's P/E ratio is -3.76. In terms of profitability, TDOC's ROE is -0.13%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, TDOC is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
TDOC vs EVH Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, EVH has a market cap of 518M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while EVH trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas EVH's P/E ratio is 35.42. In terms of profitability, TDOC's ROE is -0.13%, compared to EVH's ROE of -0.99%. Regarding short-term risk, TDOC is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check EVH's competition here
NRC Health (NASDAQ: NRC)
TDOC vs NRC Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, NRC has a market cap of 492.4M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while NRC trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas NRC's P/E ratio is 26.65. In terms of profitability, TDOC's ROE is -0.13%, compared to NRC's ROE of +0.48%. Regarding short-term risk, TDOC is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
TDOC vs SLGC Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SLGC's P/E ratio is -3.04. In terms of profitability, TDOC's ROE is -0.13%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, TDOC is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
TDOC vs SLGCW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, TDOC's ROE is -0.13%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, TDOC is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
TDOC vs TBRG Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas TBRG's P/E ratio is 9.37. In terms of profitability, TDOC's ROE is -0.13%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, TDOC is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
TDOC vs MPLN Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas MPLN's P/E ratio is -0.23. In terms of profitability, TDOC's ROE is -0.13%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, TDOC is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
TDOC vs SY Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SY has a market cap of 314.9M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SY trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SY's P/E ratio is -7.27. In terms of profitability, TDOC's ROE is -0.13%, compared to SY's ROE of -0.16%. Regarding short-term risk, TDOC is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
TDOC vs TRHC Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas TRHC's P/E ratio is -4.27. In terms of profitability, TDOC's ROE is -0.13%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, TDOC is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
TDOC vs SMFR Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SMFR's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, TDOC is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
TDOC vs SPOK Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SPOK has a market cap of 222.4M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SPOK trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SPOK's P/E ratio is 17.75. In terms of profitability, TDOC's ROE is -0.13%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, TDOC is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
TDOC vs AMWL Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, AMWL has a market cap of 202.2M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while AMWL trades at $11.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas AMWL's P/E ratio is -2.69. In terms of profitability, TDOC's ROE is -0.13%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, TDOC is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check AMWL's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
TDOC vs LFMDP Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, LFMDP has a market cap of 156.9M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while LFMDP trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas LFMDP's P/E ratio is -709.24. In terms of profitability, TDOC's ROE is -0.13%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, TDOC is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check LFMDP's competition here
LifeMD, Inc. (NASDAQ: LFMD)
TDOC vs LFMD Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, LFMD has a market cap of 151.9M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while LFMD trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas LFMD's P/E ratio is -6.28. In terms of profitability, TDOC's ROE is -0.13%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, TDOC is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check LFMD's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
TDOC vs OPRX Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, OPRX has a market cap of 149.2M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while OPRX trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas OPRX's P/E ratio is 7.29. In terms of profitability, TDOC's ROE is -0.13%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, TDOC is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check OPRX's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
TDOC vs CPSI Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CPSI's P/E ratio is -183.80. In terms of profitability, TDOC's ROE is -0.13%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, TDOC is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
TDOC vs HCAT Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, HCAT has a market cap of 117.5M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while HCAT trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas HCAT's P/E ratio is 7.95. In terms of profitability, TDOC's ROE is -0.13%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, TDOC is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
TDOC vs AUGX Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas AUGX's P/E ratio is -4.99. In terms of profitability, TDOC's ROE is -0.13%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, TDOC is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
TDOC vs CCLD Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CCLD has a market cap of 105.8M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CCLD trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CCLD's P/E ratio is 9.58. In terms of profitability, TDOC's ROE is -0.13%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, TDOC is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
TDOC vs WORX Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, WORX has a market cap of 88M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas WORX's P/E ratio is -6.40. In terms of profitability, TDOC's ROE is -0.13%, compared to WORX's ROE of -0.35%. Regarding short-term risk, TDOC is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check WORX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
TDOC vs DH Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, DH has a market cap of 84.7M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while DH trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas DH's P/E ratio is 3.09. In terms of profitability, TDOC's ROE is -0.13%, compared to DH's ROE of -0.79%. Regarding short-term risk, TDOC is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
TDOC vs FORA Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas FORA's P/E ratio is -24.11. In terms of profitability, TDOC's ROE is -0.13%, compared to FORA's ROE of -0.17%. Regarding short-term risk, TDOC is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
TDOC vs CCLDP Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CCLDP's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
TDOC vs SNCE Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SNCE's P/E ratio is -0.27. In terms of profitability, TDOC's ROE is -0.13%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, TDOC is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
TDOC vs AKLI Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas AKLI's P/E ratio is -0.71. In terms of profitability, TDOC's ROE is -0.13%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, TDOC is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
TDOC vs SHLT Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SHLT's P/E ratio is -3.87. In terms of profitability, TDOC's ROE is -0.13%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, TDOC is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMD)
TDOC vs ONMD Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, ONMD has a market cap of 33M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while ONMD trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas ONMD's P/E ratio is -3.62. In terms of profitability, TDOC's ROE is -0.13%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, TDOC is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check ONMD's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
TDOC vs SHCRW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, TDOC's ROE is -0.13%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, TDOC is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
TDOC vs ONMDW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, ONMDW has a market cap of 31.1M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas ONMDW's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, TDOC is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
TDOC vs STRM Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas STRM's P/E ratio is -2.40. In terms of profitability, TDOC's ROE is -0.13%, compared to STRM's ROE of -0.65%. Regarding short-term risk, TDOC is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
TDOC vs RNLX Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas RNLX's P/E ratio is -0.33. In terms of profitability, TDOC's ROE is -0.13%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, TDOC is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
TDOC vs LIFW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas LIFW's P/E ratio is -0.02. In terms of profitability, TDOC's ROE is -0.13%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, TDOC is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
TDOC vs BBLN Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas BBLN's P/E ratio is -0.04. In terms of profitability, TDOC's ROE is -0.13%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, TDOC is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check BBLN's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
TDOC vs BFRG Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, BFRG has a market cap of 10.1M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while BFRG trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas BFRG's P/E ratio is -1.18. In terms of profitability, TDOC's ROE is -0.13%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, TDOC is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
TDOC vs ETAO Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas ETAO's P/E ratio is -0.01. In terms of profitability, TDOC's ROE is -0.13%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, TDOC is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
TDOC vs MGRX Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, MGRX has a market cap of 6.8M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while MGRX trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas MGRX's P/E ratio is -0.30. In terms of profitability, TDOC's ROE is -0.13%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, TDOC is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
TDOC vs UPH-WT Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, TDOC is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
TDOC vs UPH Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas UPH's P/E ratio is -0.07. In terms of profitability, TDOC's ROE is -0.13%, compared to UPH's ROE of -1.05%. Regarding short-term risk, TDOC is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check UPH's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
TDOC vs PEARW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas PEARW's P/E ratio is -0.00. In terms of profitability, TDOC's ROE is -0.13%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, TDOC is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
TDOC vs PEAR Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas PEAR's P/E ratio is -0.08. In terms of profitability, TDOC's ROE is -0.13%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, TDOC is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
TDOC vs OTRK Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas OTRK's P/E ratio is -0.02. In terms of profitability, TDOC's ROE is -0.13%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, TDOC is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
TDOC vs CMAX Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CMAX's P/E ratio is -0.00. In terms of profitability, TDOC's ROE is -0.13%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, TDOC is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
TDOC vs BFRGW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, TDOC's ROE is -0.13%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, TDOC is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check BFRGW's competition here
Aclarion, Inc. (NASDAQ: ACON)
TDOC vs ACON Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas ACON's P/E ratio is -0.27. In terms of profitability, TDOC's ROE is -0.13%, compared to ACON's ROE of -0.59%. Regarding short-term risk, TDOC is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
TDOC vs LIFWZ Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, TDOC is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check LIFWZ's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
TDOC vs HCTI Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, HCTI has a market cap of 975.4K. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while HCTI trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas HCTI's P/E ratio is -0.11. In terms of profitability, TDOC's ROE is -0.13%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, TDOC is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
TDOC vs VSEEW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, TDOC's ROE is -0.13%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, TDOC is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
TDOC vs MSPRZ Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, TDOC is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MSPRZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
TDOC vs VSEE Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, VSEE has a market cap of 245.6K. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while VSEE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas VSEE's P/E ratio is -0.03. In terms of profitability, TDOC's ROE is -0.13%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, TDOC is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check VSEE's competition here
Akerna Corp. (NASDAQ: KERN)
TDOC vs KERN Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas KERN's P/E ratio is -0.01. In terms of profitability, TDOC's ROE is -0.13%, compared to KERN's ROE of -0.20%. Regarding short-term risk, TDOC is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
TDOC vs KERNW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas KERNW's P/E ratio is -0.00. In terms of profitability, TDOC's ROE is -0.13%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, TDOC is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
TDOC vs LIFWW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas LIFWW's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, TDOC is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
TDOC vs CMAXW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CMAXW's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, TDOC is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
TDOC vs ZCMD Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, ZCMD has a market cap of 32.1K. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while ZCMD trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, TDOC's ROE is -0.13%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, TDOC is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
TDOC vs ACONW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, ACONW has a market cap of 13.6K. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas ACONW's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, TDOC is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check ACONW's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
TDOC vs CHNG Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CHNG's P/E ratio is -152.72. In terms of profitability, TDOC's ROE is -0.13%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, TDOC is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CHNG's competition here
NantHealth, Inc. (NASDAQ: NH)
TDOC vs NH Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, NH has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas NH's P/E ratio is -0.12. In terms of profitability, TDOC's ROE is -0.13%, compared to NH's ROE of +0.35%. Regarding short-term risk, TDOC is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check NH's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
TDOC vs KURIU Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, KURIU has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas KURIU's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, TDOC is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check KURIU's competition here
CareCloud, Inc. (NASDAQ: MTBC)
TDOC vs MTBC Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas MTBC's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, TDOC is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MTBC's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
TDOC vs IMS Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, IMS has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas IMS's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to IMS's ROE of +0.27%. Regarding short-term risk, TDOC is less volatile compared to IMS. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check IMS's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
TDOC vs AFFX Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas AFFX's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, TDOC is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check AFFX's competition here
Castlight Health, Inc. (NYSE: CSLT)
TDOC vs CSLT Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CSLT's P/E ratio is -37.27. In terms of profitability, TDOC's ROE is -0.13%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, TDOC is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CSLT's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
TDOC vs SMFRW Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas SMFRW's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, TDOC is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SMFRW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
TDOC vs MSPRV Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas MSPRV's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to MSPRV's ROE of N/A. Regarding short-term risk, TDOC is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MSPRV's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
TDOC vs NAVA Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas NAVA's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, TDOC is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for TDOC.Check NAVA's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
TDOC vs CHNGU Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CHNGU's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, TDOC is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
TDOC vs CNVY Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CNVY's P/E ratio is -71.50. In terms of profitability, TDOC's ROE is -0.13%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, TDOC is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
TDOC vs MTBCP Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas MTBCP's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
TDOC vs MTBCO Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas MTBCO's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.13%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check MTBCO's competition here
Cerner Corporation (NASDAQ: CERN)
TDOC vs CERN Comparison September 2026
Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TDOC stands at 1.2B. In comparison, CERN has a market cap of 0. Regarding current trading prices, TDOC is priced at $6.50 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TDOC currently has a P/E ratio of -6.57, whereas CERN's P/E ratio is 55.84. In terms of profitability, TDOC's ROE is -0.13%, compared to CERN's ROE of +0.14%. Regarding short-term risk, TDOC is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CERN's competition here